Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492993 · ClinicalTrials.gov registry record · NA
Using Community Health Navigators to Advance Cancer Screening Adherence
A NA study, sponsored by Gallaudet University.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
NCT06492993: Completed NA study, sponsored by Gallaudet University.
NCT06492993 is a NA study that has completed, run by Gallaudet University. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06492993, a NA study, has completed, sponsored by Gallaudet University.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
Study Summary
Intervention to promote cancer screenings among deaf, deafblind, and hard of hearing participants who have not received screening within the recommended guideline.
Primary Outcome
Completion of at least one recommended cancer screening as measured by documentation of the actual screening
Interventions
- OTHER Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2023-09-30 |
| Est. Completion | 2026-03-20 |
| Phase | NA |
What the finished NCT06492993 record still lists
NCT06492993 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Education is the first listed.
NCT06492993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06492993 about?
NCT06492993 is a clinical study titled "Using Community Health Navigators to Advance Cancer Screening Adherence". Intervention to promote cancer screenings among deaf, deafblind, and hard of hearing participants who have not received screening within the recommended guideline.
What is the current status of trial NCT06492993?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2023-09-30. Estimated completion is 2026-03-20.
What interventions are being tested in trial NCT06492993?
The interventions under investigation include: Education (OTHER).
Who is sponsoring clinical trial NCT06492993?
This trial is sponsored by Gallaudet University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06492993's enrollment target sits among peer trials
184 581st of 2000 higher than 1,417 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI